Media are welcome to download these materials for an overview of the MenaQ7® brand and its exclusive global supplier, NattoPharma, as well as an indication of the substantial clinical evidence demonstrating MenaQ7®’s benefits for human health.

Press inquiries can be directed to Kate Quackenbush, Director of Communications, at kate.quackenbush@nattopharma.com

    We value your privacy

    We access information on a device, such as cookies and process personal data, such as unique identifiers and standard information sent by a device for personalised ads and content, ad and content measurement, and audience insights, as well as to develop and improve products.

    With your permission we and our partners may use precise geolocation data and identification through device scanning. You may click to consent to our and our partners’ processing as described above. Alternatively you may click to refuse to consent or access more detailed information and change your preferences before consenting.

    Please note that some processing of your personal data may not require your consent, but you have a right to object to such processing. Your preferences will apply to this website only. You can change your preferences at any time by returning to this site or visit our privacy policy.